Abstract
Purpose To evaluate whether the systemic oxidative stress biomarkers increased in patients with vitreomacular traction syndrome (VMT). Methods This study compared 25 patients diagnosed with VMT with 20 healthy controls. As a biomarker of systemic oxidative stress, malondialdehyde (MDA) was measured. Total oxidant status (TOS) and total antioxidant status (TAS) were measured to evaluate the systemic oxidant status. Results Serum MDA values were significantly higher among the patients (p < 0.001). The ideal cut-off value for MDA was determined to be 22.1 µmol/L, with 80% sensitivity and 75% specificity. The between-group differences were not statistically significant for TOS or TAS (p = 0.326 and p = 0.698, respectively). Conclusion Increased MDA levels suggest that systemic oxidative stress may play a role in VMT.
Funding Information
  • Health Science University, Kayseri City Training and Research Hospital, Foundation of Scientific Research Support funded this study (2019-22)

This publication has 25 references indexed in Scilit: